Literature DB >> 10999878

Clinical course of patients with major histocompatibility complex class II deficiency.

M A Saleem1, P D Arkwright, E G Davies, A J Cant, P A Veys.   

Abstract

The clinical course of 10 children who have been diagnosed with major histocompatibility complex (MHC) class II deficiency (bare lymphocyte syndrome) in the UK over the past eight years is described. They have had a generally poor prognosis, with only two of the 10 still alive despite eight attempts at bone marrow transplantation in six patients. Overwhelming viral infection was the predominant cause of death. Alternative transplant strategies or novel therapies are required for these patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10999878      PMCID: PMC1718526          DOI: 10.1136/adc.83.4.356

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  17 in total

1.  Correction of the hyper-IgM syndrome after liver and bone marrow transplantation.

Authors:  N Hadzić; A Pagliuca; M Rela; B Portmann; A Jones; P Veys; N D Heaton; G J Mufti; G Mieli-Vergani
Journal:  N Engl J Med       Date:  2000-02-03       Impact factor: 91.245

2.  Imaging the less seriously head injured child.

Authors:  J F Glasgow; S J McGovern
Journal:  Arch Dis Child       Date:  2000-04       Impact factor: 3.791

3.  Reliability of percentage ideal weight for height.

Authors:  V J Poustie; R M Watling; D Ashby; R L Smyth
Journal:  Arch Dis Child       Date:  2000-08       Impact factor: 3.791

4.  Is the ethos of medical practice in community paediatrics compatible with that in public health?

Authors:  S Stewart-Brown
Journal:  Arch Dis Child       Date:  2000-08       Impact factor: 3.791

5.  Lung deposition of aerosol--a comparison of different spacers.

Authors:  H J Zar; E G Weinberg; H J Binns; F Gallie; M D Mann
Journal:  Arch Dis Child       Date:  2000-06       Impact factor: 3.791

6.  Re-vaccination of 421 children with a past history of an adverse vaccine reaction in a special immunisation service.

Authors:  M Gold; H Goodwin; S Botham; M Burgess; M Nash; A Kempe
Journal:  Arch Dis Child       Date:  2000-08       Impact factor: 3.791

7.  Indirect measurements of sweat electrolyte concentration in the laboratory diagnosis of cystic fibrosis.

Authors:  M E Heeley; D A Woolf; A F Heeley
Journal:  Arch Dis Child       Date:  2000-05       Impact factor: 3.791

Review 8.  Combined immunodeficiency with defective expression in MHC class II genes.

Authors:  C Griscelli; B Lisowska-Grospierre; B Mach
Journal:  Immunodefic Rev       Date:  1989

9.  Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome.

Authors:  C Klein; B Lisowska-Grospierre; F LeDeist; A Fischer; C Griscelli
Journal:  J Pediatr       Date:  1993-12       Impact factor: 4.406

10.  Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient.

Authors:  E W Petersdorf; T A Gooley; C Anasetti; P J Martin; A G Smith; E M Mickelson; A E Woolfrey; J A Hansen
Journal:  Blood       Date:  1998-11-15       Impact factor: 22.113

View more
  13 in total

1.  Gastrointestinal Manifestations of Non-AIDS Immunodeficiency.

Authors:  Robert P. McCabe
Journal:  Curr Treat Options Gastroenterol       Date:  2002-02

Review 2.  Periodontal and other oral manifestations of immunodeficiency diseases.

Authors:  M E Peacock; R M Arce; C W Cutler
Journal:  Oral Dis       Date:  2016-10-10       Impact factor: 3.511

3.  Major histocompatibility complex class II deficiency in Kuwait: clinical manifestations, immunological findings and molecular profile.

Authors:  Waleed Al-Herz; Osama Alsmadi; Motasem Melhem; Mike Recher; Francesco Frugoni; Luigi D Notarangelo
Journal:  J Clin Immunol       Date:  2012-11-10       Impact factor: 8.317

4.  Defective dendritic cell maturation in a child with nucleotide excision repair deficiency and CD4 lymphopenia.

Authors:  L Racioppi; C Cancrini; M L Romiti; F Angelini; S Di Cesare; E Bertini; S Livadiotti; M G Gambarara; G Matarese; F Lago Paz; M Stefanini; P Rossi
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

5.  Major histocompatibility complex class II deficiency complicated by Mycobacterium avium complex in a boy of mixed ethnicity.

Authors:  Dimana Dimitrova; Peck Y Ong; Maurice R G O'Gorman; Joseph A Church
Journal:  J Clin Immunol       Date:  2014-05-01       Impact factor: 8.317

6.  The 752delG26 mutation in the RFXANK gene associated with major histocompatibility complex class II deficiency: evidence for a founder effect in the Moroccan population.

Authors:  Hamid Naamane; Ouafaa El Maataoui; Fatima Ailal; Abdelhamid Barakat; Siham Bennani; Jilali Najib; Mohammed Hassar; Rachid Saile; Ahmed Aziz Bousfiha
Journal:  Eur J Pediatr       Date:  2010-04-23       Impact factor: 3.183

7.  Clinical experience in T cell deficient patients.

Authors:  Theresa S Cole; Andrew J Cant
Journal:  Allergy Asthma Clin Immunol       Date:  2010-05-13       Impact factor: 3.406

8.  Clinical, Immunological, and Molecular Findings in Five Patients with Major Histocompatibility Complex Class II Deficiency from India.

Authors:  Jahnavi Aluri; Maya Gupta; Aparna Dalvi; Snehal Mhatre; Manasi Kulkarni; Gouri Hule; Mukesh Desai; Nitin Shah; Prasad Taur; Ramprasad Vedam; Manisha Madkaikar
Journal:  Front Immunol       Date:  2018-02-16       Impact factor: 7.561

9.  Clinical, immunological and genetic features in eleven Algerian patients with major histocompatibility complex class II expression deficiency.

Authors:  Réda Djidjik; Nesrine Messaoudani; Azzedine Tahiat; Yanis Meddour; Samia Chaib; Aziz Atek; Mohammed Elmokhtar Khiari; Nafissa Keltoum Benhalla; Leila Smati; Abdelatif Bensenouci; Mourad Baghriche; Mohammed Ghaffor
Journal:  Allergy Asthma Clin Immunol       Date:  2012-08-03       Impact factor: 3.406

10.  Hypoxemic Bronchiolitis Related to Major Histocompatibility Class II Deficiency.

Authors:  S Hammami; H Besbès; S Hadded; K Lajmi; L Ghédira; Ch B Meriem; M N Guediche
Journal:  Case Rep Med       Date:  2013-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.